Cited by 627Migraine and Headache StudiesMusculoskeletal pain and rehabilitationTraumatic Brain Injury Research

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)

Blumenfeld, AM, Varon, SF, Wilcox, TK, Buse, DC, Kawata, AK, Manack, A, Goadsby, PJ, Lipton, RB·2011·Cephalalgia

Open this paper in CoChat — free account

Abstract

Background: Migraine imposes significant burden on patients, their families and health care systems. In this study, we compared episodic to chronic migraine sufferers to determine if migraine status predicted headache-related disability, health-related quality of life (HRQoL) and health care resource utilization. Methods: A Web-based survey was administered to panelists from nine countries. Participants were classified as having chronic migraine (CM), episodic migraine (EM) or neither using a validated questionnaire. Data collected and then analyzed included sociodemographics, clinical characteristics, Migraine Disability Assessment, Migraine-Specific Quality of Life v2.1, Patient Health Questionnaire and health care resource utilization. Findings: Of the respondents, 5.7% had CM and 94.3% had EM, with CM patients reporting significantly more severe disability, lower HRQoL, higher levels of anxiety and depression and greater health care resource utilization compared to those with EM. Interpretation: These results provide evidence that will enhance our understanding of the factors driving health care costs and will contribute to development of cost-effective health care strategies.

Integrity signals

Registry

Crossref · 10.1177/0333102410381145

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Oxford University Press eBooks · doi:10.1037/10518-009 · Cited by 19,766
An Ultra-Brief Screening Scale for Anxiety and Depression: The PHQ–4
Kroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2009) · Psychosomatics · doi:10.1016/s0033-3182(09)70864-3 · Cited by 4,261
The global burden of headache: A documentation of headache prevalence and disability worldwide
Stovner, L., Hagen, K., Jensen, R., Katsarava, Z., Lipton, R., Scher, A., Steiner, T., & Zwart, J.-A. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01288.x · Cited by 2,444
Self-citation
Migraine prevalence, disease burden, and the need for preventive therapy
Lipton, R. B., Bigal, M. E., Diamond, M., Freitag, F., Reed, M. L., & Stewart, W. F. (2007) · Neurology · doi:10.1212/01.wnl.0000252808.97649.21 · Cited by 2,337
Self-citation
Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
Lipton, R. B., Stewart, W. F., Diamond, S., Diamond, M. L., & Reed, M. (2001) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.041007646.x · Cited by 2,268
Self-citation
Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability
Stewart, W. F., Lipton, R. B., Dowson, A. J., & Sawyer, J. (2001) · Neurology · doi:10.1212/wnl.56.suppl_1.s20 · Cited by 1,210
Self-citation
The Global Burden of Disease Study
Menken, M., Munsat, T. L., & Toole, J. F. (2000) · Archives of Neurology · doi:10.1001/archneur.57.3.418 · Cited by 1,059

Show all 50 references

Research works printed but not linked: 4

Harwood RH, 2004, Bull World Health Organ, 82, 251
Hung PH, 2006, Acta Neurol Taiwan, 15, 43
Kroenke K, 2009, Psychosomatics, 50, 613
Stewart WF, 1994, Neurology, 44, S24

Sorted by citations

Items 401–500 of 626

The Role of Attachment Style, Adverse Childhood Experiences and Dissociation in Migraine
Mays, I., Flynn, J., McGuire, B. E., & Egan, J. (2021) · Journal of Trauma & Dissociation · doi:10.1080/15299732.2021.1989114 · Cited by 8
Comparison of Pain-Related and Psychological Variables between Acute and Chronic Migraine Patients, and Factors Affecting Headache Chronicity.
Emadi, F., Sharif, F., Shaygan, M., Shaygan, M., Sharifi, N., & Ashjazadeh, N. (2019) · Europe PMC (PubMed Central) · doi:10.30476/ijcbnm.2019.44994 · Cited by 7
Practical Insights on the Identification and Management of Patients with Chronic Migraine
Blumenfeld, A. M., Dueland, A. N., Evers, S., Jenkins, B., Martelletti, P., & Sommer, K. (2022) · Pain and Therapy · doi:10.1007/s40122-022-00387-9 · Cited by 8
Self-citation
Shift in diagnostic classification of migraine after initiation of preventive treatment with eptinezumab: post hoc analysis of the PROMISE studies
Pozo‐Rosich, P., Dodick, D. W., Ettrup, A., Hirman, J., & Cady, R. K. (2022) · BMC Neurology · doi:10.1186/s12883-022-02914-9 · Cited by 7
Headache from the Doctors' Perspective
Gil‐Gouveia, R. (2014) · European Neurology · doi:10.1159/000355278 · Cited by 7
Peripheral Neuromodulation for Treatment of Chronic Migraine Headache
Tavanaiepour, D., & Levy, R. M. (2013) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2013.08.010 · Cited by 7
Approaches to treatments of chronic migraine associated with medication overuse: a comparison between different intensity regimens
Raggi, A., Schiavolin, S., Leonardi, M., Grazzi, L., Usai, S., Curone, M., & D’Amico, D. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2134-0 · Cited by 7
Management of chronic migraine in Japan
Watanabe, Y., Takashima, R., Iwanami, H., Suzuki, S., Igarashi, H., & Hirata, K. (2013) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.53.1228 · Cited by 7
A Critical Review of Botulinum Toxin Type A in the Prophylactic Treatment of Chronic Migraine in Adults
Mimeh, H., Magrin, A. M. F., Myers, S. R., & Ghanem, A. M. (2018) · Aesthetic Surgery Journal · doi:10.1093/asj/sjy224 · Cited by 7
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity
Onan, D., Bentivegna, E., & Martelletti, P. (2022) · Toxins · doi:10.3390/toxins15010029 · Cited by 10
Endoscopic neural blockade for rhinogenic headache and facial pain: 2011 update
Rodman, R. E., & Dutton, J. M. (2012) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21035 · Cited by 7
The economic burden of migraine: a nationwide cost-of-illness approach from the year 2020 European Health Survey in Spain
Fernández‐Ferro, J., Ordás, C., Rejas, J., Ferro-Rey, B., Gómez-Lus, S., & Andrés, J. M. L. (2025) · Neurología (English Edition) · doi:10.1016/j.nrleng.2025.06.002 · Cited by 6
Menopause hormone therapy, migraines, and thromboembolism
Khandelwal, S., Meeta, M., & Tanvir, T. (2021) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2021.11.011 · Cited by 6
Economic burden of migraine in Singapore
Ong, J. J. Y., Patnaik, D., Chan, Y. C., Simon, O., & Finkelstein, E. A. (2020) · Cephalalgia Reports · doi:10.1177/2515816320908241 · Cited by 6
Reductions in acute medication use and healthcare resource utilization in patients with chronic migraine: a secondary analysis of a phase 3, randomized, double-blind, placebo-controlled study of galcanezumab with open-label extension (REGAIN)
Tobin, J. A., Joshi, S., Ford, J. H., Nichols, R., Foster, S. A., Ruff, D. D., Detke, H. C., & Aurora, S. K. (2022) · Journal of Medical Economics · doi:10.1080/13696998.2022.2109335 · Cited by 6
Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse
Starling, A. J., Cady, R. K., Buse, D. C., Buzby, M., Spinale, C., Steinberg, K., Lenaburg, K., & Kymes, S. M. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01725-2 · Cited by 6
Self-citation
Early use of erenumab in US real-world practice
Bogdanov, A., Chia, V., Bensink, M. E., Urman, R., Fischer, L., Rasmussen, S., Szekely, C. A., & Kallenbach, L. (2021) · Cephalalgia Reports · doi:10.1177/25158163211020419 · Cited by 6
Migraine Patient Care Model Preferences in a Community Practice
Stern, J. I., Ebbert, J. O., Vierkant, R. A., & Young, N. P. (2023) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200131 · Cited by 4
Chronic migraine: a therapeutic challenge for clinicians
Irimia, P., Carmona‐Abellán, M., & Martínez‐Vila, E. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.726612 · Cited by 6
Improving to Four or Fewer Monthly Headache Days Per Month Provides a Clinically Meaningful Therapeutic Target for Patients with Chronic Migraine
Kaniecki, R. G., Friedman, D. I., Asher, D., Hirman, J., & Cady, R. K. (2023) · Pain and Therapy · doi:10.1007/s40122-023-00525-x · Cited by 5
Estimating quality of life in a headache referral population based on Migraine Disability Assessment Scale and Headache Impact Test
Togha, M., Ahadi, M. S., Jafari, E., Vahabi, Z., Naderi, F., Nasergivehchi, S., Haghighi, S., Ghorbani, Z., Farham, F., Paknejad, S. M. H., et al. (2020) · Current Journal of Neurology · doi:10.18502/cjn.v19i2.4944 · Cited by 5
Characteristics of Adults with Migraine in Alberta, Canada: A Population-Based Study
Richer, L. P., Wong, K. O., Martins, K. J. B., Rajapakse, T., Amoozegar, F., Becker, W. J., & Klarenbach, S. W. (2021) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2021.68 · Cited by 5
HIT-6 and EQ-5D-5L in patients with migraine: assessment of common latent constructs and development of a mapping algorithm
Gonçalves, A. S. O., Пантели, Д., Neeb, L., Kurth, T., & Aigner, A. (2021) · The European Journal of Health Economics · doi:10.1007/s10198-021-01342-9 · Cited by 7
Health co-inquiry in migraine: Online participation and stakeholder experiences before and during the COVID-19 pandemic
Baucke, C. L., Seifert, L. S., & Kaelber, K. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260376 · Cited by 5
Three men in a boat: The comparison of the combination therapy of botulinum toxin and greater occipital nerve block with bupivacaine, with botulinum toxin monotherapy in the management of chronic migraine
Karaoğlan, M. (2023) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2023.107609 · Cited by 5
Currently Available Interventions for the Management of Migraine Pain
Singh, R. K., Pandey, S. K., Singh, S., Chittoda, A., & Chaudhari, S. A. (2024) · Springer eBooks · doi:10.1007/978-981-97-4529-6_11 · Cited by 5
Role of Epidemiological Data Within the Drug Development Lifecycle: A Chronic Migraine Case Study
Manack, A. N., Catherine, C., & Kaplowitz, H. J. (2012) · InTech eBooks · doi:10.5772/32343 · Cited by 5
Self-citation
Clinical treatment of chronic and episodic migraine with onabotulinumtoxinA in a real-world setting
Juanes, F. V., Gómez‐Esteban, J. C., Fernández‐Valle, T., Matute-Nieves, A., Velasco, J. A., Lloret-Villas, M. I., & Ugarriza-Serrano, I. (2018) · Drugs & Therapy Perspectives · doi:10.1007/s40267-018-0511-5 · Cited by 5
Clinical characteristics and patient‐reported outcomes of chronic and episodic migraine patients at a US tertiary headache center: A retrospective observational study
Ahmed, Z. A., Honomichl, R. D., Thompson, S. F., Cohen, J. M., Schuster, A. T., Thompson, N. R., Lapin, B. R., Udeh, B. L., Campos, V. R., Krasenbaum, L. J., et al. (2023) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14527 · Cited by 6
Results of a Web-Based Survey on 2565 Greek Migraine Patients in 2023: Demographic Data, Imposed Burden and Satisfaction to Acute and Prophylactic Treatments in the Era of New Treatment Options
Dermitzakis, E. V., Argyriou, A. A., Bilias, K., Barmpa, E., Liapi, S., Rikos, D., Xiromerisiou, G., Soldatos, P., & Vikelis, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13102768 · Cited by 6
Treatment of migraine: a review of disease burden and an update on the therapeutic landscape for pharmacists
Patel, N., Barnhart, R., Konkol, P., Varda, J., Nelson, R., & Smith, T. (2020) · Drugs & Therapy Perspectives · doi:10.1007/s40267-020-00801-2 · Cited by 5
Onabotulinumtoxin A for prophylaxis in chronic migraine: preliminary data from headache regional centre of aosta valley
Lia, C., Tosi, P., Giardini, G., Caligiana, L., & Bottacchi, E. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1764-y · Cited by 5
Kronik Migrenin Aydınlanmaya Başlayan Yüzü
Özemir, Z. A., & Baykan, B. B. (2013) · Nöro Psikiyatri Arşivi · doi:10.4274/npa.y7244 · Cited by 5
Epidemiology, Progression, Prognosis, and Comorbidity of Migraine
Lipton, R. B., Sollars, C. M., & Buse, D. C. (2013) · Headache · doi:10.1002/9781118678961.ch5 · Cited by 5
Self-citation
Peripheral occipital nerve stimulation to treat chronic refractory migraine
Ashkan, K., & Dowson, A. J. (2013) · British Journal of Hospital Medicine · doi:10.12968/hmed.2013.74.2.85 · Cited by 5
Functional and Control Integration of an ICU, LIS and PACS Information System
Katehakis, D. G., Tsiknakis, M., Armaganidis, A., & Orphanoudakis, S. C. (1997) · Studies in health technology and informatics · doi:10.3233/978-1-60750-887-8-15 · Cited by 5
Cost of illness and labour market disaffiliation among patients with migraine discontinuing triptan treatment: A Danish nationwide register study from 1995 to 2021
Ashina, M., Steiner, T. J., Hansen, J. M., Hauberg, D. S., Lønberg, U. S., Spanggaard, M., Olsen, J., Stallknecht, S. E., & Hansen, T. F. (2024) · Cephalalgia · doi:10.1177/03331024241269758 · Cited by 4
The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
Meydanal, Y. E., Şenışık, S., & ŞİRİN, H. (2025) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14951 · Cited by 4
Real world treatment patterns and unmet needs of migraine preventive treatments in Japan: JMDC claims analysis
Takeshima, T., Ahmadyar, G., Duan, M., Yamazaki, T., Inoue, S., & Nishimura, C. (2025) · Current Medical Research and Opinion · doi:10.1080/03007995.2025.2552277 · Cited by 4
Cartera de servicios y cuadro básico de indicadores de calidad para las unidades de cefalea: estudio de consenso
Carrillo, I., Pozo‐Rosich, P., Guilabert, M., García, E. I., Gómez, J. P., Porta-Etessam, J., Peral, Á. L. G., & Mira, J. J. (2019) · Revista de Neurología · doi:10.33588/rn.6803.2018293 · Cited by 4
Zervikaler „joint position error“ bei Kopfschmerzen
Meise, R., Lüdtke, K., Probst, A., Stude, P., & Schöttker-Königer, T. (2019) · Der Schmerz · doi:10.1007/s00482-019-0369-z · Cited by 4
Variations in Patterns of Utilization and Charges for the Care of Headache in North Carolina, 2000-2009: A Statewide Claims’ Data Analysis
Hurwitz, E. L., Vassilaki, M. E., Li, D., Schneider, M., Stevans, J. M., Phillips, R. B., Phelan, S. P., Lewis, E. A., & Armstrong, R. C. (2016) · Journal of Manipulative and Physiological Therapeutics · doi:10.1016/j.jmpt.2016.02.008 · Cited by 4
Migraine Treatment Using Erenumab: Can Lead to a Cognitive and Psychological Qualitative Improvement?
Torrisi, M., Corallo, F., Buono, V. L., Cara, M. D., Grugno, R., Presti, R. L., Quartarone, A., & Cola, M. C. D. (2023) · Medicina · doi:10.3390/medicina59050936 · Cited by 4
Barriers to healthcare access in patients with chronic pain or potential migraine in Japan: a cross-sectional internet survey
Karasawa, Y., Yamaguchi, K., Nakano, S., Nozawa, K., & Iseki, M. (2023) · Frontiers in Pain Research · doi:10.3389/fpain.2023.1271438 · Cited by 4
Burden of Episodic Migraine, Chronic Migraine, and Medication Overuse Headache in Alberta
McMullen, S., Graves, E., Ekwaru, J. P., Pham, T., Mayer, M., Ladouceur, M.-P., Hubert, M., Bougie, J. K., & Amoozegar, F. (2023) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2023.289 · Cited by 4
Migraine and Disability Rights
Shapiro, R. E. (2012) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000418652.08268.9f · Cited by 4
IncobotulinumtoxinA (Xeomin®) and OnabotulinumtoxinA (Botox®) for Chronic Migraine Headache: Experience with Higher Doses and Changes to the Injection Technique
Fragoso, G. S. M. (2014) · Journal of Neurological Disorders · doi:10.4172/2329-6895.1000192 · Cited by 4
Headache management in a Veteran population: First considerations
Williams, K. A. (2020) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000539 · Cited by 4
Changes in use of acute and preventive medications for migraine after erenumab initiation over 12 months: A United States retrospective cohort study
Multani, J. K., Urman, R., Park, A. S., Gill, K., Vuvu, F., Sun, K., Patel, L. B., Stockl, K. M., Hawkins, K., Rhyne, C., et al. (2024) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14820 · Cited by 4
Valutazione economica della tossina botulinica per la profilassi dell’emicrania cronica
Ruggeri, M., Carletto, A., & Marchetti, M. (2013) · PharmacoEconomics Italian Research Articles · doi:10.1007/s40276-013-0003-5 · Cited by 4
Dizziness Handicap and Its Contributing Factors in Patients With Migraine
Lee, S. H., Kang, Y., Sohn, J., & Cho, S. (2019) · Pain Practice · doi:10.1111/papr.12767 · Cited by 4
Integrated headache care at the outpatient headache center of the University Hospital of Munich
Rohling, S., Funk, A., Ruscheweyh, R., Schankin, C. J., Straube, A. M., & Kamm, K. (2018) · Clinical and Translational Neuroscience · doi:10.1177/2514183x18786844 · Cited by 4
Unmet needs in the management of migraine in Greece from the perspective of medical experts: a Delphi consensus
Kourlaba, G., Vikelis, M., Karapanayiotides, T., Solakidi, A., Trafalis, D. T., Lioliou, K., Andriopoulos, P., Παναγιώτου, Α., & Mitsikostas, D. D. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1556808 · Cited by 3
Migraine-related disability according to headache frequency subclassifications: A systematic review and meta-analysis
Matharu, M. S., Silberstein, S. D., Yuan, H., Edgar, D. R., Colman, R., Schwedt, T. J., Lantéri‐Minet, M., & Obermann, M. (2025) · Cephalalgia · doi:10.1177/03331024251385965 · Cited by 5
Reporting Quality and Risk of Bias Analysis of Published RCTs Assessing Anti-CGRP Monoclonal Antibodies in Migraine Prophylaxis: A Systematic Review
Rikos, D., Vikelis, M., Dermitzakis, E. V., Soldatos, P., Rallis, D., Rudolf, J., Andreou, A. P., & Argyriou, A. A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13071964 · Cited by 3
A Dutch cost-effectiveness analysis of fremanezumab versus best supportive care in patients with chronic migraine and inadequate response to prior preventive therapy
Wolters, S., Carpay, J. A., Pronk, M. H., Zuurbier, K. W. M., Driessen, M. T., Lyras, L., & Postma, M. J. (2024) · BMC Neurology · doi:10.1186/s12883-024-03697-x · Cited by 3
Real-World Experience of Erenumab in Patients with Migraine in Germany: The SPECTRE Study
Gaul, C., Gendolla, A., Holle, D., Göbel, H., Koch, M., Baufeld, C., & Weiss, C. (2024) · Pain and Therapy · doi:10.1007/s40122-024-00658-7 · Cited by 3
Health care resource utilization in the management of patients with Arginase 1 Deficiency in the US: a retrospective, observational, claims database study
Sawad, A. B., Jackimiec, J., Bechter, M., Hull, M., Yeaw, J., Wang, Y., & Díaz, G. A. (2022) · Journal of Medical Economics · doi:10.1080/13696998.2022.2089517 · Cited by 3
Ağrı. Ahead of Print: AGRI-37880 | DOI: 10.14744/agri.2022.37880 Evaluation of Pupil Diameter for Pain Assessment in Interventional Headache Management
Yılmaz, R. (2022) · Ağrı - The Journal of The Turkish Society of Algology · doi:10.14744/agri.2022.37880 · Cited by 3
Real-world experience of OnabotulinumtoxinA treatment in female patients with chronic migraine: a qualitative study using in-depth interviews
Palacios‐Ceña, D., Ordás, C., Casas‐Limón, J., Pérez‐Corrales, J., Güeita‐Rodríguez, J., Navalón, J. A. A., & Cuadrado, M. L. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2255215 · Cited by 5
Evolving migraine management: Lithuania's telemedicine experience
Andruškevičius, S., Petrosian, D., Dapkutė, A., Jokubaitis, M., & Ryliškienė, K. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1388100 · Cited by 3
Integrative East–West Medicine Intervention for Chronic Daily Headache: A Case Report and Care Perspective
Laube, J., Araujo, T. S., & Taw, L. B. (2020) · Global Advances in Health and Medicine · doi:10.1177/2164956120905817 · Cited by 3
Evidence review group report: Botulinum toxin type A for the prophylaxis of headaches in adults with chronic migraine
Royle, P., Cummins, E., Walker, C., Chong, S., Kandala, N., & Waugh, N. R. (2011) · Cited by 3
Validity and Reliability of the Fibromyalgia Rapid Screening Tool Among Individuals with Chronic Daily Headache: A Clinic-Based Study
Cho, S., Perrot, S., Sohn, J., Bae, J. S., & Chu, M. K. (2018) · Pain Medicine · doi:10.1093/pm/pny216 · Cited by 4
Improving access to care for patients with migraine in a remote Pacific population
Baker, V. B., & Hack, N. K. (2020) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000774 · Cited by 3
The effects of a unique medium chain triglyceride complex on migraine symptoms: A beta pilot study
Wolkodoff, N. E., Haase, G. M., & Firger, R. A. (2020) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2020.8.3.0479 · Cited by 3
Migraine Trust Virtual 2020 – Digital presentations
(2020) · Cephalalgia · doi:10.1177/0333102420962305 · Cited by 3
OnabotulinumtoxinA Reduces Health Resource Utilization in Chronic Migraine: PREDICT Study
Becker, W. J., Boudreau, G., Finkelstein, I., Graboski, C. L., Ong, M., Christie, S. N., Sommer, K., Bhogal, M., & Davidovic, G. (2022) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2022.43 · Cited by 3
Real world, open label prospective experience of supplementation with a fixed combination of magnesium, vitamin B2, feverfew, andrographis paniculata and coenzyme Q10 (Vivinor®) for episodic migraine prophylaxisPreprint
Vikelis, M., Dermitzakis, E. V., Vlachos, G. S., Soldatos, P., Spingos, K. C., Litsardopoulos, P., Kararizou, E. G., & Argyriou, A. A. (2020) · doi:10.21203/rs.3.rs-50685/v1 · Cited by 3
Onabotulinum toxin A vs. incobotulinum toxin A for the treatment of chronic migraine: a retrospective reviewPreprint
Lucchese, S., Daripa, B., & Pulimamidi, S. (2023) · Research Square · doi:10.21203/rs.3.rs-2624326/v1 · Cited by 3
The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysisPreprint
Lampl, C., MaassenVanDenBrink, A., Amin, F. M., Deligianni, C. I., Gil‐Gouveia, R., Jassal, T., del Río, M. S., Reuter, U., Uludüz, D., Versijpt, J. J., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2789503/v1 · Cited by 3
Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
Wang, S., Kim, B., Wang, H., Zhou, J., Wan, Q., Yu, T., Lian, Y., Arkuszewski, M., Ecochard, L., Snellman, J., et al. (2024) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14733 · Cited by 2
Reliability and Validity Study of the Migraine Interictal Burden Scale-4 in Turkish
Karacı, R., Sünbül, E. A., Dikmen, P. Y., Aydınlar, E. I., Bilgic, F. A., Öksüz, N., Özçelik, E. U., Atalar, A. Ç., Taşdelen, S., Ekizoğlu, E., et al. (2024) · Neurological Sciences and Neurophysiology · doi:10.4103/nsn.nsn_159_23 · Cited by 2
The second interim analysis of Italian participants enrolled in the real-world, Pan-European, prospective, observational, Phase 4 PEARL study of fremanezumab effectiveness
Vernieri, F., Ambrosini, A., Bartolini, M., Cevoli, S., Coppola, G., d’Onofrio, F., Simone, R. D., Granato, A., Guérzoni, S., Prudenzano, M. P., et al. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08504-0 · Cited by 2
Early and Sustained Shift in Headache Day Frequency Following Eptinezumab Treatment in Adults With Migraine for Whom 2–4 Previous Preventive Treatments Have Failed: A Post Hoc Analysis of the Randomized DELIVER Trial
Tassorelli, C., Starling, A. J., Awad, S. F., Lee, X. Y., Pickering, L., Asher, D., Soni-Brahmbhatt, S., Sperling, B., & Goadsby, P. J. (2025) · European Journal of Neurology · doi:10.1111/ene.70460 · Cited by 2
Self-citation
The Role of Income and Health Insurance on Migraine Care: Results of the OVERCOME (US) Study
Lipton, R. B., Martinez, B., Buse, D. C., Mehrabadi, A. S., Zagar, A. J., Cohen, F., Shapiro, R. E., Hoyt, M. L., Sait, A., Nicholson, R. A., et al. (2026) · Advances in Therapy · doi:10.1007/s12325-025-03428-9 · Cited by 2
Self-citation
Migraine, comorbidity, and risks of severe maternal and neonatal morbidity or mortality: a population-based cohort study
Albanese, C. M., Bondy, S. J., Lay, C. L., Vyas, M. V., Li, Z., Guan, J., & Brown, H. K. (2026) · American Journal of Epidemiology · doi:10.1093/aje/kwag008 · Cited by 2
Evaluating dual calcitonin gene‐related peptide antagonists for chronic migraine prevention
Graves, K. S., To, J., Paige, H., Kennedy, A. G., Sprouse‐Blum, A. S., Devine, D., & MacDougall, J. (2026) · Headache The Journal of Head and Face Pain · doi:10.1111/head.70057 · Cited by 2
Clinical evaluation of individualised multimodal physiotherapy and acupuncture treatment for patients with chronic daily headache
Persson, A. L., van der Pals, M., & Carlsson, C. P. O. (2015) · Physical Therapy Reviews · doi:10.1179/1743288x15y.0000000019 · Cited by 2
The effect of abobotulinum toxin A in the prophylactic treatment of refractory migraine
Baf, M. M. F., Alipour, A., Homam, M., Khorashadizadeh, M., & Saadat, M. B. (2016) · Turkish Journal Of Neurology · doi:10.4274/tnd.15986 · Cited by 2
Demographic and clinical characteristics of prevention-eligible patients with migraine in the US: a linked national survey and administrative claims database study
Foster, S. A., Balkaran, B. L., Cambron‐Mellott, M. J., Samaan, K. H., Mason, O., Ye, W., Rowland, J., & Jaffe, D. H. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1865749 · Cited by 2
Migraine aura: results from an art contest
Dias, B. D. F., Oliveira, A. B., Mercante, J. P. P., Viana, M., Queiroz, L. P., & Peres, M. F. P. (2020) · Headache Medicine/Revista Headache Medicine · doi:10.48208/headachemed.2020.4 · Cited by 2
The importance of an early onset of migraine preventive disease control: A roundtable discussion
Gottschalk, C. H., Basu, A., Blumenfeld, A. M., Torphy, B. D., Marmura, M. J., Pavlovic, J. M., Dumas, P. K., Lalvani, N., & Buse, D. C. (2022) · Cephalalgia Reports · doi:10.1177/25158163221134593 · Cited by 2
Self-citation
A Retrospective Comparison of Onabotulinum Toxin A and Incobotulinum Toxin A in Terms of Efficacy, Tolerability, Duration of Effect, and Pain on Injection Administration Site for the Treatment of Chronic Migraine
Lucchese, S., Daripa, B., & Pulimamidi, S. (2024) · Cureus · doi:10.7759/cureus.53969 · Cited by 2
The use of onabotulinum toxin type A and other neurotoxins for the treatment of chronic migraine: An American Headache Society survey study
Agarwal, U., Hamilton, K., Ali, A. S., & Mathew, P. G. (2025) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2025.108960 · Cited by 2
Practical neurology Part 7 ‐ Recurrent headaches with visual disturbance
Zagami, A. S., & Goddard, S. (2012) · The Medical Journal of Australia · doi:10.5694/mja11.11533 · Cited by 2
Épidémiologie, évolution, pronostic de la migraine et des céphalées primaires chez l’enfant et l’adolescent
Annequin, D., Tourniaire, B., & Amouroux, R. (2014) · Springer eBooks · doi:10.1007/978-2-8178-0235-0_3 · Cited by 2
Societal impact of migraine chronification
Igarashi, H. (2013) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.53.1225 · Cited by 2
Newer Research and its Significance
Martin, V. T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800901-7.00024-0 · Cited by 2
Assessment of Migraine Disability Using the Migraine Disability Assessment Questionnaire in Young Nigerians
Ezeala‐Adikaibe, B., Onyekonwu, C. L., Ijoma, U. N., Mbadiwe, N., Ekenze, O. S., Orjioke, C., Young, E. E., Chime, P. E., Onodugo, O. D., Anyim, O. B., et al. (2018) · World Journal of Neuroscience · doi:10.4236/wjns.2018.84032 · Cited by 2
Are antimigraine drugs that influence CGRP levels justified?
Piechal, A., Domitrz, I., Kurkowska‐Jastrzębska, I., & Mirowska-Guzel, D. M. (2019) · Pharmacological Reports · doi:10.1016/j.pharep.2019.03.002 · Cited by 2
A Cross-sectional Observational Study to Assess Clinical Characteristics, Prescription Patterns and Health-related Quality of Life in Patients with Migraine at a Tertiary Care Teaching Hospital
Parekh, K. (2023) · Chettinad Health City Medical Journal · doi:10.24321/2278.2044.202344 · Cited by 2
Хроническая мигрень: современные принципы менеджмента (обзор литературы)
Delva, M. Y., & Nikiforova, O. S. (2016) · INTERNATIONAL NEUROLOGICAL JOURNAL · doi:10.22141/2224-0713.2.80.2016.74019 · Cited by 2
A comprehensive assessment of headache characteristics, management and burden of migraine in comparison with tension type headache in Turkey: Results of a cross-sectional survey of adult patientsPreprint
Ertaş, M., Saip, S., Karadaş, Ö., Öztürk, V., Uygunoğlu, U., Özge, A., Üçler, S., Aydınlar, E. I., Dikmen, P. Y., Üzüner, N., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1755769/v1 · Cited by 2
Galcanezumab (Emgality)
Reimbursement Team (2022) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2022.275 · Cited by 1
Measuring incremental burdens associated with increasing preventive-treatment failures among adults with migraine: a retrospective, cross-sectional study
Ailani, J., Chen, N., Patel, A., Spence, N., Sternbach, N., Tellor, K. B., Lewis, M. O., & Brown, J. D. (2025) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864251337431 · Cited by 1
Prophylactic treatment of migraine in real clinical practice
Starikova, N. L. (2025) · Russian Journal of Pain · doi:10.17116/pain20252302163 · Cited by 1
Comparative Long-Term Outcomes of Pulsed and Lesion Radiofrequency of the Greater Occipital Nerve in Chronic Migraine: A 12-Month Cohort Study
Yilmaz, A., & Küçükbingöz, Ç. (2025) · Medicina · doi:10.3390/medicina61111893 · Cited by 1
Real-world effectiveness of eptinezumab in chronic migraine—increase in good days in three subgroups: psychiatric comorbidities, prior subcutaneous anti-calcitonin gene-related peptide therapy, and migraine-associated brain fog
Argoff, C. E., Khan, F., Herzog, S., Smith, R. M., Soni-Brahmbhatt, S., Asher, D., Awad, S. F., Grossman, S. W., Patel, F. P., & Buse, D. C. (2025) · The Journal of Headache and Pain · doi:10.1186/s10194-025-02165-2 · Cited by 1
Self-citation
Patient-Reported Outcomes During the Acute Treatment of Migraine with Zavegepant Nasal Spray: Results from a 52-Week, Open-Label Study
Lipton, R. B., Mosher, L., & Fountaine, R. J. (2025) · Pain and Therapy · doi:10.1007/s40122-025-00800-z · Cited by 1
Self-citation

Authors: Blumenfeld, A., Varon, S., Wilcox, T., Buse, D., Kawata, A., Manack, A., Goadsby, P., & Lipton, R.
Affiliations: The Neurology Center, USA.
Allergan (United States) (US)
United BioSource Corporation, USA.
Albert Einstein College of Medicine (US)
University of California, USA.
Montefiore Headache Center and Albert Einstein College of Medicine, USA.
Corresponding author: Blumenfeld, AM
Venue: Cephalalgia
Publisher: SAGE Publications
Published: 2010-09-02
Volume: 31
Issue: 3
Pages: 301-315
ISSN: 0333-1024 (ISSN-L)
1468-2982
DOI: 10.1177/0333102410381145
OpenAlex: W2142670324
Cited by: 627
References: 50
Citations by year: 2026: 22 · 2025: 34 · 2024: 53 · 2023: 50 · 2022: 41 · 2021: 58 · 2020: 79 · 2019: 49 · 2018: 39 · 2017: 25 · 2016: 34 · 2015: 38 · 2014: 26 · 2013: 27 · 2012: 38
FWCI: 16.79
Type: journal article
Language: en
Open access: closed
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Cephalalgia (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (submittedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
Keywords: chronic migraine, episodic migraine, headache-related disability, health-related quality of life, healthcare resource utilization, anxiety, depression, health care costs
MeSH terms: Adult, Chronic Disease, Cross-Sectional Studies, Data Collection, Disability Evaluation, Female, Health Resources, Humans, Male, Migraine Disorders, Online Systems, Quality of Life, Cost of Illness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks